Influence of age on the risk of severe exacerbation and asthma control in childhood

Journal of Asthma

Volumn 48, Issue 1, 2011, Pages 65-68

  Mahut, Bruno ^a,b,c,d   Trinquart, Ludovic ^b,c,e   Delclaux, Christophe ^b,c,e  

^a Cabinet La Berma   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c Mosquito Respiratory Research Group   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

asthma; childhood; control; exacerbation

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; FLUTICASONE; PREDNISONE; ANTIASTHMATIC AGENT;

AGE; ARTICLE; ASTHMA; ATOPY; AUTUMN; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DISEASE EXACERBATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SEASON; SPRING; DISEASE COURSE; PATHOPHYSIOLOGY;

AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 79952169705     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2010.529225     Document Type: Article

References (11)

1. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.
2. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170:836-844. (Pubitemid 39346477)
3. The Global Initiative for Asthma (GINA). 2007. Available at: http://www.ginasthma.com/. Accessed October 7, 2010.
4. Kuehni CE, Frey U. Age-related differences in perceived asthma control in childhood: guidelines and reality. Eur Respir J 2002; 20:880-889. (Pubitemid 35175124)
5. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353:364-369. (Pubitemid 29088164)
6. Ayres JG, Jyothish D, Ninan T. Brittle asthma. Paediatr Respir Rev 2004; 5:40-44. (Pubitemid 38256164)
7. Covar RA, Szefler SJ, Zeiger RS, Sorkness CA, Moss M, Mauger DT, et al. Factors associated with asthma exacerbations during a longterm clinical trial of controller medications in children. J Allergy Clin Immunol 2008; 122: 741 e4-747 e4.
8. ANAES. Recommandations pour le suivi médical des patients asthmatiques adultes et adolescents. 2004. Available at: www.hassante.fr/ portail/upload/docs/application/pdf/. Accessed October 7, 2010.
9. Mahut B, Peiffer C, Thibaudon M, Chevalier-Bidaud B, Defrance-Hutinet MF, Trinquart L, et al. What does a single exhaled nitric oxide measurement tell us in asthmatic children? J Asthma 2009; 46:810-814.
10. Sorkness CA, Lemanske RF Jr., Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007; 119:64-72. (Pubitemid 46043379)
11. Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007; 119:73-80. (Pubitemid 46037824)